Related Experiment Videos
[Suppurative arthritis caused by Gemella morbillorum in a patient with rheumatoid arthritis of the knee]
Fang-Gen Tang1, Fen-Lian Yuan, Jia-Kai Liu
1Medical College, Jinggangshan University, Ji'an 343000, China. tangfanggen72@163.com
Abstract:
Rheumatoid arthritis of the knee is a common disease, but suppurative arthritis caused by Gemella morbillorum in the same joint is rare. We report a case of suppurative arthritis caused by Gemella morbillorum in a patient with rheumatoid arthritis. Because the infection symptoms was not typical, the diagnosis was delayed, and the delayed diagnosis and therapy led to a poor outcome of the patient.
Insights
A rare Gemella morbillorum infection caused knee joint suppurative arthritis in a rheumatoid arthritis patient. Delayed diagnosis of atypical symptoms led to poor outcomes, highlighting the need for vigilance.
Area of Science:
- Rheumatology
- Infectious Diseases
- Microbiology
Background:
- Rheumatoid arthritis commonly affects the knee joint.
- Suppurative arthritis is a serious joint infection.
Observation:
- A rare case of suppurative arthritis caused by Gemella morbillorum in a patient with rheumatoid arthritis is presented.
- The patient presented with atypical infection symptoms, delaying diagnosis.
Findings:
- Gemella morbillorum, a rare pathogen, was identified as the cause of suppurative arthritis.
- Delayed diagnosis and treatment resulted in a poor clinical outcome for the patient.
Implications:
- This case underscores the importance of considering rare pathogens in joint infections, especially in immunocompromised patients.
- Early and accurate diagnosis is crucial for effective management and improved outcomes in suppurative arthritis.
- Clinicians should maintain a high index of suspicion for unusual infections presenting with atypical symptoms in rheumatoid arthritis patients.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management